Cargando…

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study

Aims: Whether pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma agonist, increases the risk of developing bladder cancer has been debated for several years. The aim of this study was to investigate the in vitro effects of PIO on normal urothelial transitional epithelium (NUTE) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shao-ling, Wang, Ji-jiao, Chen, Ming, Xu, Lu, Li, Nan, Luo, Yi-li, Bu, Le, Zhang, Man-na, Li, Hong, Su, Ben-li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820852/ https://www.ncbi.nlm.nih.gov/pubmed/29483814 http://dx.doi.org/10.7150/ijms.22408

Ejemplares similares

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
por: Gupta, Sunil, et al.
Publicado: (2015)

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)

Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
por: Qu, Hua, et al.
Publicado: (2017)

Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
por: Tseng, Chin-Hsiao
Publicado: (2012)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Li, Sheyu, et al.
Publicado: (2013)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
por: Neumann, A., et al.
Publicado: (2012)

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
por: DONG, YOUHONG, et al.
Publicado: (2016)

A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone
por: Agrawal, Prabhat, et al.
Publicado: (2021)

Pioglitazone-Induced Acute Rhabdomyolysis
por: Slim, Raoudha, et al.
Publicado: (2009)

Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects
por: Shahid, Muhammad, et al.
Publicado: (2020)

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
por: Lewis, James D., et al.
Publicado: (2011)

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
por: Piccinni, Carlo, et al.
Publicado: (2011)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
por: Balaji, V., et al.
Publicado: (2014)

Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy
por: Wang, Ling-Xu, et al.
Publicado: (2017)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
por: Jin, Sang-Man, et al.
Publicado: (2014)

The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
por: Lee, Mei-Yueh, et al.
Publicado: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Derosa, Giuseppe, et al.
Publicado: (2009)

Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
por: Zou, Cong, et al.
Publicado: (2013)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Kwang Joon, et al.
Publicado: (2013)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Sang-Yong
Publicado: (2012)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Song, Sun Ok, et al.
Publicado: (2012)

Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study
por: Kemp‐Casey, Anna, et al.
Publicado: (2022)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice
por: Peng, Jun, et al.
Publicado: (2014)

Effects of red mold dioscorea with pioglitazone, a potentially functional food, in the treatment of diabetes
por: Chen, Chien-Li, et al.
Publicado: (2015)

Pioglitazone-Loaded Cartilage-Targeted Nanomicelles (Pio@C-HA-DOs) for Osteoarthritis Treatment
por: Chen, Junyan, et al.
Publicado: (2023)

Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy
por: Zou, Jia-Nan, et al.
Publicado: (2017)

Investigation of the antibacterial activity of pioglitazone
por: Masadeh, Majed M, et al.
Publicado: (2011)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Pioglitazone: A prudent prescription
por: Kalra, Sanjay, et al.
Publicado: (2013)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hs35t0c1m3trcj8ll54blpc409